Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Spano

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Optometry and Vision Science : Official Publication of the American Academy of Optometry|June 5, 2018
Evaluation of a Paradigm to Investigate Detection of Road Hazards when Using a Bioptic TelescopeAlex R Bowers, P Matthew Bronstad, Lauren P Spano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 26, 2022
Genetic landscape of indolent and aggressive Kaposi sarcomasG G Malouf, X Lu, R Mouawad, et al.
Lancet (London, England)|January 6, 2001
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international studyI McKeith, T Del Ser, P Spano, et al.
Medical Oncology (Northwood, London, England)|April 1, 2003
Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcomaJ-P Spano, J-C Soria, M Kambouchner, et al.
Cell Death & Disease|March 4, 2011
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injuryA Lanzillotta, I Sarnico, R Ingrassia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II studyJ Taïeb, T Lecomte, T Aparicio, et al.
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 5, 2015
[Global brain metastases management strategy: a multidisciplinary-based approach]P Métellus, A Tallet, F Dhermain, et al.
Bulletin Du Cancer|January 21, 2010
Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximabA Barbier, J Domont, N Magné, et al.
Critical Reviews in Oncology/Hematology|April 11, 2008
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancerM Bouchahda, T Macarulla, J P Spano, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Optometry and Vision Science : Official Publication of the American Academy of Optometry|June 5, 2018
Evaluation of a Paradigm to Investigate Detection of Road Hazards when Using a Bioptic TelescopeAlex R Bowers, P Matthew Bronstad, Lauren P Spano, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 26, 2022
Genetic landscape of indolent and aggressive Kaposi sarcomasG G Malouf, X Lu, R Mouawad, et al.
Lancet (London, England)|January 6, 2001
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international studyI McKeith, T Del Ser, P Spano, et al.
Medical Oncology (Northwood, London, England)|April 1, 2003
Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcomaJ-P Spano, J-C Soria, M Kambouchner, et al.
Cell Death & Disease|March 4, 2011
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injuryA Lanzillotta, I Sarnico, R Ingrassia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II studyJ Taïeb, T Lecomte, T Aparicio, et al.
British Journal of Cancer|September 3, 2009
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine aloneH S Wasan, G M Springett, C Chodkiewicz, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 5, 2015
[Global brain metastases management strategy: a multidisciplinary-based approach]P Métellus, A Tallet, F Dhermain, et al.
Bulletin Du Cancer|January 21, 2010
Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximabA Barbier, J Domont, N Magné, et al.
Critical Reviews in Oncology/Hematology|April 11, 2008
Cetuximab efficacy and safety in a retrospective cohort of elderly patients with heavily pretreated metastatic colorectal cancerM Bouchahda, T Macarulla, J P Spano, et al.
Pageof 12